secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2026-05-18T20:33:00+00:00
Accession:  0001213900-26-058495
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals appoints Eric Francois to Board of Directors
-----------------------------------------------------------------------

- Eric Francois appointed to board effective May 13, 2026; compensation consistent with standard non-employee director arrangements.
- Francois brings over 20 years of healthcare and life sciences leadership; currently independent director at CERo Therapeutics (CERO).
- Previously CFO of SCYNEXIS (SCYX), raised over $300M through FDA approval and launch; earlier MD in healthcare investment banking at Raymond James and Credit Suisse.
- No family relationships or material transactions with company; appointment not pursuant to any arrangement with others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/0001213900-26-058495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/ea0291366-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-058495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer